Protocol summary

Summary
Aim of this study comparison of frequency of cesarean section and the average of delivery ‎‎phases between Epidural analgesia versus no analgesia in labor. This study is clinical trials ‎and double blind.120 patients will divide in two groups. Women will done delivery with ‎epidural anesthesia (4-6 milliliter Marcain 0/125 percent and single dose 5 micro gram ‎Fentanyl and preservative dose Marcain 0/125 percent and 0/002 percent in 6-10 milliliter ‎in hours) and women pregnant will perform delivery without analgesia. We will record ‎incidence cesarean and mean of time of delivery phases after delivery.‎ Inclusion criteria: pregnant woman; single fetus; pregnant women candidates vaginal delivery; pregnant women candidates epidural; nuliparous; ASA class I and II; 37 to 42 weeks Exclusion criteria: Mothers with more than one fetus; multiparty mothers; patients referring to urgency; Patients with topical anesthetics and narcotic; block placenta infection; failure in epidural anesthesia

General information

Acronym
IRCT registration information
IRCT registration number: IRCT2017102420258N63
Registration date: 2017-11-16, 1396/08/25
Registration timing: registered_while_recruiting

Last update:
Update count: 0
Registration date
2017-11-16, 1396/08/25
Registrant information
Name
Fariba Farokhi
Name of organization / entity
Arak University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 86 3222 2003
Email address
f.farokhi@arakmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice Chancellor and Research, Arak University of Medical Sciences
Expected recruitment start date
2017-06-05, 1396/03/15
Expected recruitment end date
2019-06-05, 1398/03/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of frequency of cesarean section and the average of delivery ‎phases between Epidural analgesia versus no analgesia in labor
Public title
Comparison of frequency of cesarean section and the average of delivery ‎phases between Epidural analgesia versus no analgesia in labor
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: pregnant woman; single fetus; pregnant women candidates vaginal delivery; pregnant women candidates epidural; nuliparous; ASA class I and II; 37 to 42 weeks Exclusion criteria: Mothers with more than one fetus; multiparty mothers; patients referring to urgency; Patients with topical anesthetics and narcotic; block placenta infection; failure in epidural anesthesia
Age
No age limit
Gender
Male
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size: 120
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee Arak University Of Medical Sciences
Street address
Vice chancellor for research, Payambar azam complex, Basij squre, Sardasht, Arak
City
Arak
Postal code
38149578558
Approval date
2017-05-22, 1396/03/01
Ethics committee reference number
IR.ARAKMU.REC.1396.38

Health conditions studied

1

Description of health condition studied
Delivery
ICD-10 code
O80
ICD-10 code description
Single spontaneous delivery

Primary outcomes

1

Description
incidence cesarean ‎
Timepoint
after delivery
Method of measurement
mount

2

Description
Mean of time of delivery phases
Timepoint
after delivery
Method of measurement
Minute

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: Women will done delivery with epidural anesthesia (4-6 milliliter ‎Marcain 0/125 percent and single dose 5 micro gram Fentanyl and preservative dose ‎Marcain 0/125 percent and 0/002 percent in 6-10 milliliter in hours) ‎
Category
Treatment - Drugs

2

Description
Control group: Delivery is performed without analgesia.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Taleghani hospital
Full name of responsible person
Dr Maryam Shokrpour
Street address
Taleghani hospital, Emam Khomeini street
City
Arak

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Vice chancellor for research, Arak University of Medical Sciences
Full name of responsible person
Dr Anoshirvani
Street address
Vice chancellor for research, Payambar Azam Complex, Basij square, Sardasht, Arak
City
Arak
Grant name
-
Grant code / Reference number
-
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice chancellor for research, Arak University of Medical Sciences
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Dr Maryam Shokrpour
Position
Faculty member, Gynechologist
Other areas of specialty/work
Street address
Taleghani hospital, Emamkhomeini street
City
Arak
Postal code
3814957558
Phone
+98 86 3222 2003
Fax
+98 863222003
Email
m.shokrpour@yahoo.com
Web page address
-

Person responsible for scientific inquiries

Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Dr Alireza Kamali
Position
Faculty member, Anesthesiologist
Other areas of specialty/work
Street address
Valiasr Hospital, Valiasr squre, Shahid Shirodi street
City
Arak
Postal code
3814957558
Phone
+98 86 3222 2003
Fax
+98 863222003
Email
alikamaliir@yahoo.com
Web page address
-

Person responsible for updating data

Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Rezvan Rahimi
Position
Medical student
Other areas of specialty/work
Street address
Payambar Azam Complex, Basij Square, Sardasht, Arak
City
Arak
Postal code
3814957558
Phone
+98 86 3222 2003
Fax
+98 863222003
Email
rezvan.rahimi772212@gmail.com
Web page address
-

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...